This page was not found
The requested page was not found. The page you are looking for may have been deleted, renamed or is temporarily unavailable.
The requested page was not found. The page you are looking for may have been deleted, renamed or is temporarily unavailable.
Obligatory texts Hepa-Merz®
EU:
Hepa- Merz® Granules
Active substance: L-ornithine- L-aspartate
Indications: Treatment of concomitant disease and sequelae due to impaired detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy. Contains orange yellow S (E110), fructose,
For risks and side effects please read package insert and ask your doctor or pharmacist.
Version July 2019
Merz Pharmaceuticals GmbH, 60048 Frankfurt
LATAM:
Hepa- Merz® Granules
Active substance: L-ornithine- L-aspartate
Indications: Treatment of concomitant disease and sequelae due to impaired detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy. Contains orange yellow S (E110), fructose, aspartame.
For risks and side effects please read package insert and ask your doctor or pharmacist.
Version July 2019
Merz Pharmaceuticals GmbH, 60048 Frankfurt